Literature DB >> 35416887

Cerebral toxoplasmosis associated with the use of immunosuppressive treatments.

Ivone Melo Valadão1, Ana Sofia Sequeira1, Vanessa Barcelos1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35416887      PMCID: PMC9009870          DOI: 10.1590/0037-8682-0720-2021

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


× No keyword cloud information.
A 75-year-old male was admitted to the emergency department with right-sided weakness for 3 weeks and fever (38 °C). His medical history included rheumatoid arthritis treated with adalimumab and methotrexate. Neurological examination revealed right central facial palsy and right brachial hemiparesis with a motor strength of 3/5 in the right extremities. Laboratory tests did not reveal alterations. Serological tests showed positivity for toxoplasma immunoglobulin G (>300 IU/mL) with immunoglobulin M negativity. Brain magnetic resonance imaging (MRI) revealed a centered lesion without significant postcontrast enhancement (Figure 1). Even though the radiological findings were not fully conclusive, they pointed to an infectious cause. A lumbar puncture was performed and the polymerase chain reaction (PCR) for Toxoplasma gondii in the cerebrospinal fluid was positive. Despite the atypical imaging appearance, the analysis of the entire clinical picture with PCR for T. gondii positivity suggested the diagnosis of cerebral toxoplasmosis. The patient started therapy with pyrimethamine, sulfadiazine, and folinic acid. At discharge, he recovered completely from his neurological deficits. After finishing the treatment, MRI showed improvement in edema with a practically calcified lesion (Figure 2).
FIGURE 1:

Intraparenchymal lesion involving the striatocapsular and left temporal regions, without significant postcontrast enhancement and showing foci of spontaneous hypersignals in T1. Injury conditions cause molding of the ventricular system and deviation of the midline structures to the left.

FIGURE 2:

The lesion partially calcified without significant postcontrast enhancement in the left striatocapsular region. The reduction of the edema component, which does not currently extend to the temporal lobe, is more evident in T2 and FLAIR. Reduction of the mass effect on the ventricular system, with the incipient deviation of the pellucid septum to the right persisting.

The clinical signs of cerebral toxoplasmosis are vague and may mimic many other conditions . Therefore, imaging plays an essential role in diagnosis . In 70-80% cases, the lesions are enhanced in a homogeneous or ring pattern with contrast . This clinical case intends to alert the scientific community to a difficult-to-diagnose condition that presents various atypical radiological findings.
  3 in total

Review 1.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

2.  Cerebral toxoplasmosis in a patient on methotrexate and infliximab for rheumatoid arthritis.

Authors:  Swaroopa Pulivarthi; Rwoof A Reshi; Carl T McGary; Murali Krishna Gurram
Journal:  Intern Med       Date:  2015-06-01       Impact factor: 1.271

3.  Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Authors:  Florence Robert-Gangneux; Yvon Sterkers; Hélène Yera; Isabelle Accoceberry; Jean Menotti; Sophie Cassaing; Marie-Pierre Brenier-Pinchart; Christophe Hennequin; Laurence Delhaes; Julie Bonhomme; Isabelle Villena; Emeline Scherer; Frédéric Dalle; Feriel Touafek; Denis Filisetti; Emmanuelle Varlet-Marie; Hervé Pelloux; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.